Status:
UNKNOWN
Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Dengue Fever
Eligibility:
All Genders
Brief Summary
The study will collect the blood samples from 350 healthy persons and 350 persons infected with dengue fever.
Detailed Description
Research has showed that CLEC5A interacts with dengue virion directly, and is responsible for dengue virus (DV)-induced DAP12 phosphorylation. Data suggests that CLEC5A is a potential therapeutic targ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Dengue fever
Exclusion
- none
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00688389
Start Date
July 1 2007
End Date
December 31 2020
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaoshing Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan